Sign up Australia
Proactive Investors - Run By Investors For Investors

Pressure BioSciences closes first tranche of offer

Pressure cycling technology provider Pressure BioSciences closed the first tranche of the over-subscription amount of its $5mln private placement
Pressure BioSciences closes first tranche of offer
Oversubscribed deal

Pressure cycling technology provider to the life science industry Pressure BioSciences (OTCMKTS:PBIO), said on Tuesday it has closed the first tranche of the over-subscription amount of its $5mln Private Placement.

This follows the receipt of $550,000 in gross proceeds from the sixth overall closing of the offering. This closing increased the total amount raised in the offering to $5.56mln.

The initial terms of the offering limited the amount that could be raised to $6.25mln ($5mln plus a $1.25mln over-subscription amount). 

The Company recently approved an increase in the over-subscription amount to $2.5mln, which increased the capacity of the offering to a maximum of $7.5mln.  Following the sixth closing, $1.94mln remains available in the offering.

The company will issue senior secured convertible debentures with a fixed conversion price of $0.28 per restricted common share, and common stock purchase warrants exercisable into shares of restricted common stock at an exercise price of $0.40 per share.

On Tuesday, Pressure BioSciences shares were up 5.4% at $0.35.

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

myLotus kit
August 06 2018
The expansion drive is targeting an estimated 2.3mln women per year in the areas of Hebei, Shanghai, Beijing, Shangdong, Henan and Liaoning
June 07 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month
April 12 2018
Mission is to make stem cell treatments accessible and affordable to as many people as possible

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use